Skip to main content
. 2014 Sep 28;20(36):13015–13026. doi: 10.3748/wjg.v20.i36.13015

Table 3.

Endoscopic treatment as a secondary prophylaxis of variceal bleeding in patients with cirrhosis

Treatment comparisons Number of trials Number of patients Rebleeding OR (95%CI) Mortality OR (95%CI)
EVL vs sclerotherapy 20 1634 0.53 (0.42-0.67) 0.77 (0.59-0.99)
EVL vs NSBBs and IsMn 4 476 0.79 (0.62-1.00) 0.81 (0.61-1.08)
EVL vs EVL + NSBBs 9 955 0.59 (0.41-0.85) 0.71 (0.45-1.11)
EVL vs EVL + sclerotherapy 8 520 1.05 (0.67-1.64) 0.99 (0.68-1.44)
TIPS vs endoscopy 12 883 0.32 (0.24-0.43) 1.17 (0.85-1.61)

EVL: Endoscopic variceal ligation; IsMn: Isosorbide mononitrate; NSBBs: Non-selective beta-blockers; TIPS: Transjugular intrahepatic portosystemic shunt.